PMCT
PharmaCountry
+ Create
EN
Demands
Home
Products
Services
Jobs
Seekers
No categories for this tab
Retry
Regulatory Updates | Pharmacountry Insights
Home
/
Insights
/
Regulatory Updates
Regulatory Updates
FDA, EMA, TGA and global regulatory developments
#Sagent Pharmaceuticals
×
Daily News
Market Analysis
Research & Reports
Regulatory Updates
UPDATED
Regulatory Updates
Sep 12, 2026
•
3 min read
FDA Approves Sagent Pharmaceuticals' Ephedrine Sulfate Injection (ANDA214528)
The FDA has approved ANDA214528 for Ephedrine Sulfate injection, a 50 mg/mL intravenous solution manufactured by Sagent Pharmaceuticals.